Related Experiment Video

Updated: Aug 9, 2026

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
08:47

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on: April 5, 2019

[Medical indications and effectiveness of the pneumococcal conjugate vaccine]

R R Reinert1

  • 1Nationales Referenzzentrum für Streptokokken, Aachen. Reinert@rwth-aachen.de

Laryngo- Rhino- Otologie
|April 15, 2006
PubMed

Insights

Streptococcus pneumoniae causes severe infections like pneumonia and meningitis, particularly in young children. A pneumococcal conjugate vaccine, proven effective in infants, is expected to significantly decrease invasive pneumococcal disease and antibiotic resistance levels.

Area of Science:

  • Bacteriology
  • Immunology
  • Public Health

Context:

  • Streptococcus pneumoniae is a primary cause of bacterial pneumonia, meningitis, sinusitis, and otitis media globally.
  • Invasive pneumococcal disease incidence is notably high in children under two years old.
  • Pneumococcal meningitis in children results in significant sequelae (over 20% in Germany) and high mortality (7.5%).

Purpose:

  • To evaluate the impact of a 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and resistance.
  • To assess the vaccine's efficacy in preventing pneumococcal infections in infants.
  • To project the potential reduction in disease incidence and antimicrobial resistance with widespread vaccine use.

Summary:

  • A 7-valent pneumococcal conjugate vaccine demonstrated high efficacy in preventing invasive pneumococcal disease in US infants.
  • This vaccine was licensed in Europe in 2001.
  • Widespread vaccination is anticipated to lower the incidence of invasive pneumococcal disease and decrease pneumococcal resistance.

Impact:

  • Reduced incidence of severe pneumococcal infections in pediatric populations.
  • Potential decrease in antibiotic resistance associated with Streptococcus pneumoniae.
  • Improved public health outcomes through widespread immunization programs.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...